Chemotype Dominant Cbd

Chemotype Dominant CBD refers to cannabis plants that accumulate higher concentrations of cannabidiol (CBD) relative to tetrahydrocannabinol (THC), typically through selective breeding and genetic stabilization. This chemotype classification is determined by the plant's cannabinoid synthase enzymes and their expression patterns, particularly the CBDA synthase gene which favors CBD pathway metabolism. Plants within this chemotype family are commonly associated with CBD:THC ratios exceeding 1:1, with some lineages reaching 20:1 or higher. The emergence of dominant-CBD chemotypes represents decades of breeding work, with breeders selecting parent plants displaying consistent CBD-forward profiles across generations. Understanding this chemotype is foundational to modern cannabis breeding, as it informs strain development, cultivation protocols, and genetic preservation strategies.

Breeders working with dominant-CBD chemotypes focus on stabilizing the genetic markers controlling cannabinoid synthesis pathways, often through backcrossing and multi-generational selection. This chemotype serves as a breeding foundation for developing new cultivars with predictable cannabinoid profiles, making it essential for commercial breeding operations and institutional research programs.